Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease

Kawasaki disease (KD) refers to systemic vasculitis of medium-sized vessels accompanied by fever. The multifunctional protein apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) is a new biomarker for vascular inflammation. Here, we investigated the association between APE1/Ref-1 and KD...

Full description

Bibliographic Details
Main Authors: Yu-Ran Lee, Eun Young Bae, Hong Ryang Kil, Byeong-Hwa Jeon, Geena Kim
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/1/190
_version_ 1797495547740815360
author Yu-Ran Lee
Eun Young Bae
Hong Ryang Kil
Byeong-Hwa Jeon
Geena Kim
author_facet Yu-Ran Lee
Eun Young Bae
Hong Ryang Kil
Byeong-Hwa Jeon
Geena Kim
author_sort Yu-Ran Lee
collection DOAJ
description Kawasaki disease (KD) refers to systemic vasculitis of medium-sized vessels accompanied by fever. The multifunctional protein apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) is a new biomarker for vascular inflammation. Here, we investigated the association between APE1/Ref-1 and KD. Three groups, including 32 patients with KD (KD group), 33 patients with fever (Fever group), and 19 healthy individuals (Healthy group), were prospectively analyzed. APE1/Ref-1 levels were measured, and the clinical characteristics of KD were evaluated. The mean age of all patients was 2.7 ± 1.8 years, but the Healthy group participants were older than the other participants. Fever duration was longer in the KD group than in the fever group. APE1/Ref-1 levels were significantly higher in the KD group (<i>p</i> = 0.004) than in the other two groups, but there was no difference between the healthy and fever groups. APE1/Ref-1 levels did not differ according to fever duration or coronary arterial lesion but were higher in refractory KD cases than in non-refractory cases. APE1/Ref-1 levels were significantly higher during the acute phase of KD. We propose that APE1/Ref-1 could be a beneficial biological marker for the diagnosis and prognosis of KD, especially in refractory KD.
first_indexed 2024-03-10T01:50:54Z
format Article
id doaj.art-4a72b22ca7284f5aae6dade8e3381429
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T01:50:54Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-4a72b22ca7284f5aae6dade8e33814292023-11-23T13:05:19ZengMDPI AGBiomedicines2227-90592022-01-0110119010.3390/biomedicines10010190Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki DiseaseYu-Ran Lee0Eun Young Bae1Hong Ryang Kil2Byeong-Hwa Jeon3Geena Kim4Department of Physiology, College of Medicine, Chungnam National University, Daejeon 35015, KoreaDepartment of Pediatrics, College of Medicine, Chungnam National University Hospital, Chungnam National University, Daejeon 35015, KoreaDepartment of Pediatrics, College of Medicine, Chungnam National University Hospital, Chungnam National University, Daejeon 35015, KoreaDepartment of Physiology, College of Medicine, Chungnam National University, Daejeon 35015, KoreaDepartment of Pediatrics, College of Medicine, Chungnam National University Sejong Hospital, Chungnam National University, Sejong 30099, KoreaKawasaki disease (KD) refers to systemic vasculitis of medium-sized vessels accompanied by fever. The multifunctional protein apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) is a new biomarker for vascular inflammation. Here, we investigated the association between APE1/Ref-1 and KD. Three groups, including 32 patients with KD (KD group), 33 patients with fever (Fever group), and 19 healthy individuals (Healthy group), were prospectively analyzed. APE1/Ref-1 levels were measured, and the clinical characteristics of KD were evaluated. The mean age of all patients was 2.7 ± 1.8 years, but the Healthy group participants were older than the other participants. Fever duration was longer in the KD group than in the fever group. APE1/Ref-1 levels were significantly higher in the KD group (<i>p</i> = 0.004) than in the other two groups, but there was no difference between the healthy and fever groups. APE1/Ref-1 levels did not differ according to fever duration or coronary arterial lesion but were higher in refractory KD cases than in non-refractory cases. APE1/Ref-1 levels were significantly higher during the acute phase of KD. We propose that APE1/Ref-1 could be a beneficial biological marker for the diagnosis and prognosis of KD, especially in refractory KD.https://www.mdpi.com/2227-9059/10/1/190apurinic/apyrimidinic endonuclease-1/redox factor-1mucocutaneous lymph node syndromevasculitis
spellingShingle Yu-Ran Lee
Eun Young Bae
Hong Ryang Kil
Byeong-Hwa Jeon
Geena Kim
Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease
Biomedicines
apurinic/apyrimidinic endonuclease-1/redox factor-1
mucocutaneous lymph node syndrome
vasculitis
title Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease
title_full Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease
title_fullStr Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease
title_full_unstemmed Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease
title_short Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease
title_sort elevated plasma apurinic apyrimidinic endonuclease 1 redox effector factor 1 levels in refractory kawasaki disease
topic apurinic/apyrimidinic endonuclease-1/redox factor-1
mucocutaneous lymph node syndrome
vasculitis
url https://www.mdpi.com/2227-9059/10/1/190
work_keys_str_mv AT yuranlee elevatedplasmaapurinicapyrimidinicendonuclease1redoxeffectorfactor1levelsinrefractorykawasakidisease
AT eunyoungbae elevatedplasmaapurinicapyrimidinicendonuclease1redoxeffectorfactor1levelsinrefractorykawasakidisease
AT hongryangkil elevatedplasmaapurinicapyrimidinicendonuclease1redoxeffectorfactor1levelsinrefractorykawasakidisease
AT byeonghwajeon elevatedplasmaapurinicapyrimidinicendonuclease1redoxeffectorfactor1levelsinrefractorykawasakidisease
AT geenakim elevatedplasmaapurinicapyrimidinicendonuclease1redoxeffectorfactor1levelsinrefractorykawasakidisease